ALS Mouse Models Reveal Key Changes in Astrocytes
QPS Neuropharmacology
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease or Lou Gehrig’s Disease, is a degenerative disease that impacts the nervous system. Unfortunately, there are currently no effective treatments, and most ALS patients die within three to five years of diagnosis. As researchers desperately seek treatments for this devastating illness, one type of specialized …
Animal Models Support Research into Autism and Inflammation
QPS Neuropharmacology
The Mayo Clinic reports that individuals with autism spectrum disorder (ASD) tend to experience more gastrointestinal symptoms, including pain, constipation, and diarrhea, than their peers. Unfortunately, scientists have not yet established how digestive symptoms are linked to ASD. However, Harvard Medical School and MIT researchers may have found the key. These researchers worked with animal …
Mouse Model Confirms Importance of Amyloid β Peptide in AD Research
QPS Neuropharmacology
The number of Americans living with Alzheimer’s disease is expected to nearly triple by 2060. This statistic is alarming, but researchers are constantly working to slow the disease’s progression and improve symptoms in Alzheimer’s patients. Now, Science Daily reports that experts found that blocking a specific protein could improve Alzheimer’s symptoms. The researchers used the …
Cell Culture Models Could Help Patients with Rare Disease
QPS Neuropharmacology
Pompe disease is a rare lysosomal storage disease, with cases estimated at only one in every 40,000 births. While an enzyme replacement treatment for Pompe disease is available, it is time-consuming and incredibly costly to today’s patients. Left untreated, this condition can lead to early death, which is why alternative treatments are so urgent. Now, …
Could ALS Mouse Models Improve Patient Outlook?
QPS Neuropharmacology
Amyotrophic lateral sclerosis, or ALS, is a progressive neurodegenerative disease affecting up to 30,000 people in the United States, and another 5,000 people are diagnosed every year. The disease damages and kills motor neurons in the brain and the spinal cord, eventually causing muscle weakness and paralysis. While there is currently no cure for ALS, …